Immunohistochemistry Antibodies: Revolutionizing Pathological Diagnostics
Immunohistochemistry (IHC) is a powerful...
Transforming Bioproduction: A Comprehensive Analysis of the Single-use Bioreactors Market to 2030
Meticulous Research®, a leading global market research firm, has published a new report titled ‘Single-use Bioreactors Market by Product [Systems, Media Bags (2D, 3D), Filtration Assemblies], Type [Stirred-tank, Wave-induced], Cell [Mammalian, Bacterial, Yeast], Application [Commercial (MAb, Vaccine), Research], End User - Global Forecast to 2030.’The report forecasts that the single-use bioreactors market will reach $10.3 billion by 2030, growing at a compound annual growth rate (CAGR) of 15.8%. The growth is driven by increasing adoption of disposable technologies in the pharmaceutical and biotechnology industries, expansion of biopharmaceutical manufacturing capacities, rising R&D expenditures, growing acceptance of biosimilars, and a higher prevalence of chronic diseases.
Market Segmentation and Future Outlook
The market for single-use bioreactors is segmented by product, type, cell type, application, end user, and region.
Download Free Report Sample Now: https://www.meticulousresearch.com/download-sample-report/cp_id=5005
- Product: The market is divided into single-use bioreactor systems, media bags (2D, 3D, linear), filtration assemblies, and other products. In 2023, single-use bioreactor systems are expected to hold the largest market share due to their benefits such as reduced cleaning needs, smaller footprint, lower capital investment, increased flexibility, and minimized cross-contamination risks.
- Type: Stirred-tank bioreactors are anticipated to dominate the market in 2023, owing to their high preference for CHO cell lines, suspension cultures, and large-volume bio-production with fewer design challenges compared to traditional systems.
- Cell Type: The mammalian cells segment is expected to lead the market in 2023, driven by their importance in commercial and research bioproduction, including the development of complex biomolecules like monoclonal antibodies and therapeutic proteins.
- Application: The commercial bio-production segment is projected to have the largest share in 2023. This is due to the increasing prevalence of chronic diseases, rising demand for biopharmaceuticals, and supportive regulatory changes favoring biosimilars.
- End User: Contract development and manufacturing organizations (CDMOs) and contract research organizations (CROs) are expected to register the highest CAGR during the forecast period. The growth is attributed to the outsourcing trends among pharmaceutical and biopharmaceutical companies and the expansion strategies of CDMOs.
The report provides a comprehensive analysis of major regions: North America (U.S. and Canada), Europe (including Germany, France, U.K., Italy, Spain, Switzerland, Ireland, Denmark, Belgium, and the Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, and the Rest of Asia-Pacific), Latin America, and the Middle East & Africa. Europe is projected to have the largest market share in 2023 due to increased drug sales, supportive government policies for biopharmaceuticals, and expansions by various companies.
Quick Buy – Single-use Bioreactors Market- Global Opportunity Analysis And Industry Forecast (2023-2030), Research Report: https://www.meticulousresearch.com/Checkout/67912642
Key Players
The report profiles key players in the single-use bioreactors market, including Merck KGaA (Germany), Danaher Corporation (U.S.), Sartorius AG (Germany), Thermo Fisher Scientific Inc. (U.S.), Eppendorf AG (Germany), Solaris Biotechnology srl (Italy), Cellexus International Ltd. (U.K.), CESCO Bioengineering Co., Ltd. (Taiwan), PBS Biotech, Inc. (U.S.), Distek, Inc. (U.S.), and Infors AG (Switzerland).
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Please login to comment on this Post